It has been established by Kanai and Yanagisawa (1957) that kanamycin is highly active in preventing experimental guinea pig tuberculosis , and that it is also active in inhibiting the multiplication of streptomycin-, isoniazid-and PAS-resistant tubercle bacilli in vivo just like in vitro . However, it is not yet clarified whether the reverse is true or not, namely , whether kanamycin-resistant tubercle bacilli are sensitive or not to streptomycin and isoniazid. Therefore, as a part of our systematic kanamycin research, a further attempt was undertaken to examine the effect of streptomycin and isoniazid on guinea pig infection with kanamycin resistant tubercle bacilli.
Four strains of kanamycin resistant tubercle bacilli were isolated in a single step from a large population of bacillary cells of 112 strain (a virulent human type) sown on Kirchner agar medium containing 100,-g of kanamycin free base per cc. They were then subcultured three times on such medium to secure the population purity of the resistance.
Virulence test by guinea pig inoculation indicated that these four strains are pathogenic to guinea pigs just like their parent 112 strain of tubercle bacilli.
After these preliminary experiments , the main experiment was started arranging 13 normal guinea pigs weighing approximately 350g. They were intravenously infected with 0.01 mg of one of the kanamycin resistant strains of tubercle bacilli just stated above, and divided into three groups of 5, 4 and 4 animals.
The first group was treated with kanamycin, the second group was treated with streptomycin, and the third was with isoniazid. Subcutaneous drug administration of 10 mg daily dose was started 3 days after infection and continued for 28 days. Autopsy was made 7 days after the termination of treatment.
Comparative macroscopical observation was made concerning extension of tuberculous involvement, and viable bacterial cell counts were conducted, in the same way as our previous experiment (Kanai and Yanagisawa, 1957) , of surviving tubercle bacilli in the lung, liver and spleen.
In the animals treated with kanamycin , tuberculous change was severe, presenting generalized lymphnode swelling and innumerable tubercles in the liver and spleen. In the lung, extensive tuberculous lesions were observed. In the streptomycin-treated group, only one animal showed many scattered tubercles in the spleen but others were almost free from lesion. In the isoniazid group, no macroscopical change was observed in all the animals. Viable bacterial counts were summarized in Table 1 .
The 
